Lourens Bloem
Assistant Professor, Utrecht University
Dr. Lourens T. Bloem (PharmD, MSc) is an assistant professor at the Division of Pharmacoepidemiology and Clinical Pharmacology of Utrecht University (Utrecht, the Netherlands). He has been trained as a pharmacist (2016) and is currently in training as a clinical pharmacologist. At Utrecht University, he is a member of the Utrecht Young Academy and the Open Science Team of the Faculty of Science.
Dr. Bloem aims to optimise outcomes of medicines in patient care through interdisciplinary research, integrating drug regulatory science (the science of evaluating and improving drug regulatory decision-making), clinical pharmacology (the science of optimal clinical use of medicines), and (pharmaco)epidemiology (the science of ‘real-world’ effects of medicines). He focuses on innovative medicines for patients with cancers and rare diseases for which unmet medical needs are typically highest.
Among others, dr. Bloem is involved in the DARE-NL, Oncode Accelerator, and CURE4LIFE research consortia that aim to develop and facilitate sustainable patient access to new medicines to treat cancers (DARE-NL and Oncode Accelerator) and orphan diseases (CURE4LIFE). In addition, he is an active member of various professional organisations, including the International Society for Pharmacoepidemiology (ISPE), and editor of the British Journal of Clinical Pharmacology.
Presentation: The European Medicines Regulatory Database: An open science approach to regulatory science
Stakeholders have called for a public, integrated, high-quality, curated regulatory database that provides timely access to centralised, structured data concerning regulated medicines. Here, we respond to these calls with the European Medicines Regulatory Database (EMRD): a real-time, web-based, open access platform that centralises and contextualises structured and validated regulatory data about all medicines authorised by the European Commission after evaluation by the European Medicines Agency since 1995. The EMRD allows users to select, visualise, analyse, and download these data, as well as to query the underlying unstructured regulatory data sources (i.e., web pages and regulatory documents) concerning the assessment and decision-making processes for these medicines. Notably, since biotechnological innovation in particular has been a major driver of modern medicine regulatory frameworks, we have used the EMRD to perform an analysis of the evolution of authorised biological medicines, demonstrating the value that the EMRD provides.
| Contact | Connect | ||||
| Veerstraat 37 1211 HJ Hilversum Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
| Register now | |||
© Copyright 2023 by Hyphen Projects | All rights reserved |